IL6 and COVID-19: Giustino et al. (44) reported increased levels of pro-inflammatory cytokines—interleukin 6 (IL-6), interleukin 1 (IL-1), and tumor necrosis factor-alpha (TNF-α)—in COVID-19-positive patients.